Raffaella De Maria

8PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 23, 2025
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Sep 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.

Raffaella De Maria, Chiara Donini, Sonia Capellero

|Nov 27, 2024
Prognostic Significance of Microvessel Density and Hypoxic Markers in Canine Osteosarcoma: Insights into Angiogenesis and Tumor Aggressiveness.

Cecilia Gola, Marcella Massimini, Emanuela Morello

|Apr 13, 2024
Hypoxia-associated markers in the prognosis of oral canine melanoma.

Cecilia Gola, Lorella Maniscalco, Selina Iussich

|Sep 02, 2022
The mitotic regulator polo-like kinase 1 as a potential therapeutic target for c-Myc-overexpressing canine osteosarcomas.

Cecilia Gola, Luca Licenziato, Paolo Accornero

|Mar 22, 2021
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.

Davide Giacobino, Mariateresa Camerino, Federica Riccardo

Pageof 2

Frequent Collaborators

5 joint publications

Luca Aresu

3 joint publications

Matteo Olimpo

2 joint publications

Chiara Donini

2 joint publications

Letizia Vitali